Skip to main content
. 2022 Feb 18;26(5):476–485. doi: 10.1007/s10157-021-02151-3

Table 2.

Patient who received REGN-COV2 vs patients who did NOT receive REGN-COV2

REGN-COV2 ( +) REGN-COV2 (−)
Number of patients 5 15
Age 66.8 ± 12.15 71.26 ± 14.21
HD duration 6.23 ± 4.23 7.64 ± 5.83
Average CRP value on admission (mg/dl) 5.77 ± 4.85 7.51 ± 6.42
Hospitalization periods (days) 10.2 ± 2.86* 22.12 ± 15.15
Oxygen inhalation (case) 3 out of 5 (60%) 13 out of 15 (86.6%)
Duration of fever (h) 110.0 ± 84.2 160.86 ± 128.72
Dexamethasone use during hospitalization None 9 out of 15 (60.0%)
Dead (case) None 2 (13.3%)

A comparison was made between patients with mild to moderate disease who are eligible for REGN-COV2. Each values are represented as mean ± SD

*P < 0.05 by unpaired study t test